Kyverna therapeutics to present at upcoming investor conferences in september

Emeryville, calif., aug. 25, 2025 (globe newswire) -- kyverna therapeutics, inc. (nasdaq: kytx), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced that warner biddle, chief executive officer of kyverna, will present at the following upcoming conferences:
KYTX Ratings Summary
KYTX Quant Ranking